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The aim of this study was to determine the population structure based on identification of G2548A polymorphism 
in leptin gene and analyse its impact on selected traits related with lipids metabolism as well as obesity. Totally, 
236 human samples were included in SNP genotyping using PCR-RFLP method and endonuclease HhaI. The 
impact of locus was assessed for biochemical parameters: BMI, level of total, HDL and LDL cholesterol. In 
population the prevalence of A allele was detected. The highest proportion was found for heterozygous individuals 
(0.44). The observed heterozygosity indicated relative sufficient proportion of heterozygotes but the FIS index 
showed positive value (0.1) that can signalize the increase of homozygotes proportion. The association analysis 
using GLM procedure proved significant impact of LEP genotypes on each of selected parameter. The results 
showed the significant role of leptin in human nutritional status and confirmed its value as candidate gene of lipids 
metabolism disorders. 




The obesity as result from the interaction between genetic variability, environment and sedentary 
lifestyle is one of the most challenging health problems of the last century with tremendous increase in 
the prevalence (Chavarria-Avila et al., 2015; Becer et al., 2016). It is also known, that obesity is an 
important risk factor for developing type 2 diabetes mellitus, hypertension and cardiovascular diseases 
(Brunkwall et al., 2013; Cahill et al., 2014). The increasing prevalence of obesity in worldwide human 
population resulted in many studies on candidate genes that may contribute to its development. Most 
obesity predisposing genes encode the molecular components of physiological systems related to 
energy balance (Duarte et al., 2007). The leptin (LEP) is a protein hormone with structural similarities 
to long-chain helical cytokines that play a key role in regulation of food intake, increase energy 
expenditure, and modulate immune and inflammatory responses by binding and activating the leptin 
receptor (Poeggeler et al., 2010; Roszkowska-Gancarz et al., 2014).  
The LEP gene, human homologue of the rat obese gene cloned and sequenced by Zhang et al. 
(1994), is located on autosome 7 (7q31.3) and the length of its mRNA in adipose tissue is 4.5 kb 
(Mohammadzadeh et al., 2015). There are several studies indicating the significant association 
between polymorphisms in LEP gene and obesity (Duarte et al., 2006), hypertension (Mendoza-Núñez 
et al., 2006), coronary artery diseases and metabolic syndrome (Kim et al., 2008), insulin resistance 
(Chiu et al., 2004), type 2 diabetes mellitus (Han et al., 2008) and cancer (Mohammadzadeh et al., 
2015). The G2548A polymorphism (rs7799039: guanine > adenine) are studied widely because it has 
been associated with leptin production and secretion (Suriyaprom et al., 2014).  
The aim of this study was to detect the population genotype structure based on determination of LEP 
G2548A polymorphisms in human population and assess its impact on selected traits related to lipids 
metabolism.  
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2 Material and methods 
2.1 Biological samples and SNP genotyping 
In total 236 human blood samples were used to analyse the impact of LEP gene on selected 
biochemical parameters. The genomic DNA was extracted from each sample using the commercial kit 
NucleoSpin Blood (Macherey Nagel) according to manufacturer’s instruction. The concentration and 
quality of extracted DNA were tested by NanoPhotometer (Implen) measuring of the optical density at 
wave length of 260 nm. The identification of LEP G2548A polymorphism was carried out based on use 
of PCR-RFLP method and restriction endonuclease HhaI according to Ren et al. (2004). The PCR 
products and restriction fragments were visualised by horizontal electrophoresis in 2 % agarose gels in 
0.5 x TBE (140 V for 36 min) (Brody and Kern, 2004) stained by GelRed (Biotium) prior to visualization 
under UV light. 
 
2.2 Genotype structure 
The allele and genotype frequencies of LEP G2548A polymorphism were evaluated in order to 
determine the population structure by use of Genalex version 6.1 (Peakell and Smouse, 2012). The 
significance of differences between observed and expected genotype frequencies were tested based 
on Chi-square test. The population genetic indices, including observed (Ho) and expected (He) 
heterozygosity, effective allele numbers (Ne) and Wright's FIS index were calculated to assess the state 
of genetic diversity in population.  
 
2.3 Association analysis 
The analysis of LEP G2548A genotypes impact on selected biochemical parameters (BMI, total 
cholesterol, HDL cholesterol and LDL cholesterol) was performed using GLM procedure adopted in 
SAS Enterprise Guide 4.2 software (SAS Institute Inc. 2009). The significance of genotypes effect on 
biochemical parameters was tested with the involvement of other fixed effects according to following 
general linear models: 
Yijklm = Gi + Gj + Ak + CHl + Tm + eijklm 
where:   
Yijklm – BMI, Gi – effect genotypes, Gj – gender, Ak – age, CHl – level of total cholesterol, Tm – level of 
total triacylglycerols, eijklm – random error. 
Yijklm1, 2, 3 = Gi + Gj + Ak + Bl + Tm + eijklm 
where:   
Yijklm1, 2, 3 – level of total cholesterol, HDL and LDL, Gi – effect genotypes, Gj – gender, Ak – age, Bl – 
level of BMI, Tm – level of total triacylglycerols, eijklm – random error. 
 
3 Results and discussion 
The G2548A polymorphism in leptin gene has been successfully determined for each of analysed 
individual.  Using PCR-RFLP methods all tree genotype were identified in population. The obtained 
allele and genotype frequencies are presented in table 1. In population the prevalence of A allele was 
found. The highest proportion reached heterozygous individuals. The lowest distribution was observed 
for GG homozygous genotype. The non-significant differences (P > 0.05) between observed and 
expected genotype frequencies indicated Hardy-Weinberg equilibrium in population. The proportion of 
heterozygous individuals was transferred to the relative higher observed heterozygosity. However, the 
positive value of Wright's FIS index showed the increase of homozygote individuals in population. The 
effective allele number indicated balanced activity of both identified alleles. Our results are in 
accordance with previous reported studies for Turkish (Becer et al., 2016), Polish (Roszkowska-
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Table 1   Genotype structure of population based on LEP G2548A polymorphism 
Genotypes frequency Allele frequency χ2 test Ho He Ne FIS 
AA AG GG A G ns 0.45 0.49 1.98 0.10 0.32 0.44 0.24 0.54 0.46 
Ho – observed homozygosity, He – observed heterozygosity, Ne – effective allele number, PIC – 
polymorphic information content, FIS – fixation index; ns – not significant 
 
Table 2 shows the summary statistic of evaluated biochemical parameters according to the individual’s 
gender. The average BMI value obtained for both gender indicated the tendency of slight overweight 
across respondents in analysed sample. Moreover, the maximum BMI values signalized the risk of 
type II. obesity in some evaluated individuals. The average obtained levels of total and HDL 
cholesterol were across respondents optimal. The slight increase over the recommended limit was 
found only for the LDL cholesterol, but the average value signalize only low risk for individuals in 
analysed population. 
Table 2   Basic statistical variation of analysed biochemical parameters in population 
Parameter 
Men (n=116) Women (n=120) 
 s.d. xmax xmax  s.d. xmin xmax 
Age 44.89 13.72 19.00 63.00 49.13 9.98 20.00 63.00 
BMI [kg m-2] 26.40 3.96 20.02 37.00 26.83 4.23 18.60 37.00 
Total chol. [mmol l-l] 5.04 1.09 2.93 7.18 5.27 0.99 2.93 7.18 
HDL [mmol l-l] 1.69 0.42 0.89 2.47 1.84 0.33 0.92 2.47 
LDL [mmol l-l] 2.69 0.96 0.93 4.53 2.82 0.90 0.93 4.53 
 
The association analysis of LEP G2548A genotypes impact on selected biochemical parameters 
showed significant effect for each of trait (Table 3). Alongside the LEP genotype the effects of gender, 
age and total level of triacylglycerols were also analysed. Based on the involved fixed effects in linear 
models we were able to characterize the variability of parameters in average on 53.86%. Except total 
cholesterol, each of other analysed parameters in linear models showed statistically significant effect 
on BMI and level of total, LDL and HDL cholesterol. 
 
Table 3   The impact of LEP G2548A polymorphisms on analysed biochemical parameters 
Parameter 
AA AG GG Factors 
n  s.d. n  s.d. n  s.d.  






Total chol. 75 5.38** 1.05 105 5.14** 1.02 56 4.90** 1.03 
HDL 75 2.96*** 0.78 105 2.70*** 1.05 56 2.56*** 0.85 
LDL 75 1.88* 0.38 105 1.77* 0.34 56 1.63* 0.42 
*P < 0.05, **P < 0.01, ***P < 0.0001 
 
These study support previously published results about the role of LEP G2548A polymorphism in 
control of lipids metabolism (Mammès et al., 2000; Constantin et al., 2010).  The LEP gene has been 
investigated in the search for gene variants that are mainly related to pathophysiology of obesity and 
related disorders. Several single nucleotide polymorphisms have been described and one of these is 
G2548A (Becer et al., 2016). Alongside obesity, Hoffstedt et al. (2002) reported that the LEP G2548A 
variant can also affect the expression of leptin and its secretion in adipose tissue. Moreover, some of 
previous studies suggested its role also in the genetic prediction of other obesity related disorders 
including diabetes mellitus and cardiovascular diseases (Mendoza-Núñez et al., 2006; Han et al., 
2008; Kim et al., 2008). 
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4   Conclusions 
Our study confirmed the key role of leptin gene in control of nutritional organism status and indicate its 
significance in genetic evaluation in relation to the lipids metabolism disorders prediction. The 
association analysis support the previous published results that suggested the LEP G2548A 
polymorphism as genetic markers for the level of BMI and obesity related disorders. Because the 
obesity is considered as multifactorial disease and its genetic background is polygenic the involvement 
of other genes in the future research is needed. 
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